Franklin A. Neva followed by service with the US Navy at Naval Medical Research Unit-3 in Cairo, Egypt. He spent several years at Harvard University as a researcher. He became a professor at University of Pittsburgh, where he worked with Jonas Salk on a vaccine for polio. While at Pittsburgh, he also isolated ECHO 16, the virus responsible for Boston exanthem disease. This was the first description of that disease. Together with Thomas Weller, he isolated the Rubella virus in 1962. In 1964 he moved back to Harvard to head the Department of Tropical Public Health. In 1969 he joined the National Institutes
The Immune Response Corporation The Immune Response Corporation The Immune Response Corporation (IRC), founded by Jonas Salk and Kevin Kimberlin and based in Carlsbad, California, pioneered immunotherapeutic products. Francis Crick once said about Salk, “Few have made one discovery that has benefited humanity so greatly. Jonas was a man who, right to his last day, was actively in pursuit of another.” That pursuit was The Immune Response Corporation. Kimberlin “asked Salk to become lead scientific advisor for a new biotech company specializing in ‘anti-idiotypes,’ a novel vaccine technology.” Salk called the proposal “liberating.” The management team included CEO Jim Glavin, former CEO of Genetic